other treatments for epilepsy

Fish oil-derived omega-3 fatty acids are able to suppress epileptic activity in the brains of rats when administered as a long-term dietary supplement, according to a new study. Researchers from the Autonomous University of Zacatecas and University of Guadalajara, Mexico, whose report appears in Epilepsy and Behavior this month, fed female Wistar rats a fish oil supplement through mating, gestation, read more

Children with Lennox-Gastaut syndrome – a rare, often drug-resistant form of epilepsy – can be effectively treated by switching to a low-carb diet, according to a new report. Researchers from the All India Institute of Medical Sciences carried out a retrospective review of 25 paediatric patients diagnosed with the condition and switched to a modified Atkins diet between May 2009 read more

Drug-resistant epilepsies caused by brain tumours should be treated with surgery as soon as possible to prevent cognitive deterioration, according to a new study. The report, which was published in the February edition of Neurosurgery, took the form of a retrospective review of 29 paediatric patients who underwent surgical resection between 2000 and 2011. At their final follow-up, some 76 read more

Work is under way to develop a virtual training tool that will make it easier for neurosurgeons to acquire the skills needed to treat drug-resistant epilepsy, a Spanish software company has revealed. Bilbao and Madrid-based Bilbomatica announced via its official blog last week (December 26th 2013) it had received a research grant through the Ministry of Industry, Energy and Tourism. read more

A novel treatment for epilepsy has been linked to increased arterial stiffness in children and young adults, risking adverse cardiovascular conditions. The so-called ketogenic diet, which involves decreasing carbohydrate intake in favour of fatty foods, is sometimes claimed to reduce seizure frequency in people with the neurological disorder. Researchers from the University of Salerno and Second University of Naples, Italy, read more

Pharmaceutical company GlaxoSmithKline (GSK) has announced it will award $1 million (£612,000) to the researchers who are first to create “an implantable device that can read and write the body’s electrical language”. The so-called innovation prize for bioelectronics research was launched at a summit in New York last week (December 18th), organised by GSK and attended by 150 specialists from read more

Page 1 of 2512345...1020...Last »
Editorial team

Newsletter Signup

Enter your email address to receive monthly research updates